跳至主要内容
临床试验/ACTRN12619001093178
ACTRN12619001093178招募中未知

Exercise rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy: Impact and mechanisms

niversity of New South Wales0 个研究点目标入组 64 人开始时间: 2019年8月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Grade 2 or 3 chemotherapy-induced peripheral neuropathy (symptoms affecting function)
  • 2.At least 3 months post-neurotoxic cancer treatment and not planned for neurotoxic cancer treatment in the next 8 weeks
  • 3.Previously treated with cancer treatments for which neuropathy is a known side effect
  • 4.Greater than 18 years of age
  • 5.Able to provide written informed consent
  • 6.Cleared by a physician to participate in a structured exercise program

排除标准

  • 1.Eastern Cooperative Oncology Group (ECOG) performance status equal to or greater than 3
  • 2.Patients with known peripheral neuropathy prior to neurotoxic cancer treatment

研究者

相似试验